Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons.
BACKGROUND: The etiology of neurodegenerative disorders, such as the accelerated loss of dopaminergic neurons in Parkinson's disease, is unclear. Current hypotheses suggest an abnormal function of the neuronal sodium-dependent dopamine transporter DAT to contribute to cell death in the dopamine...
Main Authors: | Dirk Taubert, Gundula Grimberg, Werner Stenzel, Edgar Schömig |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC1851987?pdf=render |
Similar Items
-
Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP-induced dopaminergic toxicity
by: Ying Tai, et al.
Published: (2010) -
Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
by: Kristina Hacker, et al.
Published: (2015-01-01) -
Comparative Analysis of Opioids as Substrates and Inhibitors of the Human Organic Cation Transporter 1 (OCT1)
by: Neumann, Viktoria Elisabeth
Published: (2020) -
Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons.
by: Michela Deleidi, et al.
Published: (2011-01-01) -
Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
by: Wang Qingshan, et al.
Published: (2012-06-01)